z-logo
Premium
Phosphorylation of STAT3 by Human Serotonin 2C Receptor
Author(s) -
Maisha Musarrat,
Curtis M.E.,
Fears L.S,
Lanaghan Zeljka Miletic,
Ivy MT,
Fentress Hugh
Publication year - 2019
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.2019.33.1_supplement.807.5
Subject(s) - receptor , 5 ht receptor , microbiology and biotechnology , g protein coupled receptor , 5 ht2 receptor , 5 ht1 receptor , biology , serotonin , 5 ht5a receptor , signal transduction , hek 293 cells , endogenous agonist , agonist , pharmacology , biochemistry , dopamine receptor d1
Serotonin (5‐HT) is an indolamine neurotransmitter involved in a variety of functions including regulation of mood, appetite, sleep, learning and memory, and neuronal excitability. 5‐HT elicits its effects by binding to at least 14 different receptor subtypes that mediate both excitatory and inhibitory neurotransmission. The many classes of serotonin receptors have been subjected to significant studies in order to discern the functionality and produce effective therapeutic targets. One of the receptors, the 5‐HT 2C receptor, has been studied and used as a target for antipsychotic medication. 5‐HT 2C subtype receptor exists as a 7‐transmembrane spanning G protein‐coupled receptor (GPCR) found in the central nervous system, and is the only GPCR known to undergo RNA editing, creating 14 known isoforms in the human brain which affect its ability to couple with G proteins and other signaling proteins. The structurally similar 5‐HT 2A receptor has been shown to activate the G protein independent JAK/STAT pathway. The purpose of this study was to determine if the human 5‐HT 2C receptor also activates the JAK/STAT pathway. Human Embryonic Kidney (HEK) 293 cells were transfected with human 5‐HT 2C receptors to produce stable cell lines. Cells were then treated with vehicle (control), 5‐HT, olanzapine (antagonist), and SB206553 (inverse agonist) for 30 minutes or 1 hour. Treated cells were lysed, proteins were separated by SDS‐PAGE, and levels of phosphorylated JAK2 and STAT3 were analyzed using western blots. In cells treated for 30 minutes with vehicle, phosphorylation of STAT3 was observed in cells transfected with the 5‐HT 2C receptor but not in untransfected cells indicating constitutive phosphorylation of STAT3 by the 5‐HT 2C receptor. Upon treatment with serotonin, phosphorylated levels of STAT3 were increased in cells expressing the 5‐HT 2C receptor while STAT3 phosphorylation was completely blocked with cells treated with olanzapine or SB206553. Phosphorylated levels of JAK2 were unaffected across all treatments. Phosphorylated STAT3 levels showed the same patterns in cells expressing the 5‐HT 2C receptor when treated for 1 hour. These findings indicate that 2C receptors are activating STAT3 independently of JAK2 and may be involved in cell growth, differentiation, transcription of other STAT genes, and immune response. Future studies will examine different edited isoforms of the 5‐HT 2C receptor and whether STAT3 activation is dependent or independent of G‐protein activation to elucidate the phosphorylation mechanism of STAT3 by the human 5‐HT 2C receptors. Support or Funding Information Supported by NSF Grant HRD‐1238723 to HMF This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here